Literature DB >> 6889821

Assessment of cisplatin reactivity with peptides and proteins using reverse-phase high-performance liquid chromatography and flameless atomic absorption spectroscopy.

C M Riley, L A Sternson, A J Repta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6889821     DOI： 10.1016/0003-2697(82)90234-2

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  5 in total

Review 1.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

2.  Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model.

Authors:  S Kuriyama; M Matsumoto; A Mitoro; H Tsujinoue; T Nakatani; H Fukui; T Tsujii
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

3.  Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.

Authors:  F F Farris; F G King; R L Dedrick; C L Litterst
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

4.  Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.

Authors:  F G King; R L Dedrick; F F Farris
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

5.  Lipid metabolism adaptations are reduced in human compared to murine Schwann cells following injury.

Authors:  Sofia Meyer Zu Reckendorf; Christine Brand; Maria T Pedro; Jutta Hegler; Corinna S Schilling; Raissa Lerner; Laura Bindila; Gregor Antoniadis; Bernd Knöll
Journal:  Nat Commun       Date:  2020-05-01       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.